- Coordinator
- Vilniaus Universiteto Ligonine Santaros Klinikos, Lithuania
- Runs
- 1 October 2024 to 30 September 2027
- Status
- Running
- EU funding
- €1.5m
- Total cost
- —
- Partners
- 6 organisations in 5 countries
- Type
- Coordination and Support Action
- Grant agreement
- 101159949
What the project is doing
In the project's own words, from its summary on CORDIS.
The SCARLET (SCAling up early and late effects Research in Lithuanian childhood cancer survivors through Education and Twinning) proposal aims to increase scientific excellence and innovation capacity at Vilnius University Hospital Santaros Klinikos (VULSK) and its affiliated entity National Cancer Institute (NCI) by scaling up research activities in Lithuanian childhood cancer survivors (CCS). The area for twinning was defined based on the emerging importance of survivorship research due to the increasing number of CCS in Europe and identified gaps in Lithuania.
The key challenges addressed in the proposal are 1) lack of data on the prevalence of CCS in Lithuania exploitable in research initiatives; 2) poor transition from paediatric to adult care depriving young CCS over the age of 18 of advantages of surveillance in a research context; 3) the need to implement innovative solutions for monitoring and prevention of early and late effects through joint research activities; 4) suboptimal competences in management and administration of large-scale research projects.
Four research-intensive institutions from 4 European countries will bring to the consortium their specific expertise to address identified shortcomings. The proposal aims to build on and exploit current shared research initiatives that will be leveraged to achieve SCARLET’s goal and objectives. The twinning exercise will be implemented through secondments of Lithuanian staff to the partner premises and engagement in the research activities led by partner institutions, organisation of educational events, and participation in knowledge-of-transfer meetings.
As a result of the twinning activities, VULSK and NCI will improve their research profile and reputation, international visibility, and attractiveness. The expanded networking channels will facilitate Lithuanian professionals to join international research groups focused on survivorship research ultimately improving the quality of survival in Lithuania.
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Vilniaus Universiteto Ligonine Santaros Klinikos | Vilnius | Lithuania | Coordinator |
| Siop Europe | Bruxelles / Brussel | Belgium | Participant |
| Universitaetsklinikum Hamburg-Eppendorf | Hamburg | Germany | Participant |
| Region Hovedstaden | Hillerod | Denmark | Participant |
| Nacionalinis Vezio Institutas | Vilnius | Lithuania | Third party |
| Prinses Maxima Centrum Voor Kinderoncologie BV | Utrecht | Netherlands | Participant |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI